Anzeige
Mehr »
Login
Dienstag, 01.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kurs-Explosion voraus?: Diese kaum bekannte Aktie bohrt jetzt im Hotspot - und du erfährst es als Erster!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CR6X | ISIN: SE0015961826 | Ticker-Symbol: 9F1
München
01.04.25
10:23 Uhr
0,009 Euro
-0,002
-21,05 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
DIAGONAL BIO AB Chart 1 Jahr
5-Tage-Chart
DIAGONAL BIO AB 5-Tage-Chart

Aktuelle News zur DIAGONAL BIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrDIAGONAL BIO AB: Diagonal Bio publishes Year-End Report for 20241
21.03.DIAGONAL BIO AB: Diagonal Bio granted patent in Japan1
19.03.Nomination Committee change in Diagonal Bio AB (publ.)1
19.03.DIAGONAL BIO AB: Trading in Diagonal Bio's shares and warrants of series TO 2 on NGM Nordic SME begins today1
DIAGONAL BIO Aktie jetzt für 0€ handeln
18.03.NGM MARKET NOTICE: #25-27 Warrants issued by Diagonal Bio AB approved for listing at NGM2
14.03.NGM MARKET NOTICE: #25-23 Diagonal Bio AB approved for listing at NGM1
13.03.DIAGONAL BIO AB: Stall Courant and Diagonal Bio agree to a pilot test of LAMPlify®1
04.03.Diagonal Bio AB: Diagonal Bio has been approved for delisting from Nasdaq First North Growth Market113Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") today announces that Nasdaq has approved Diagonal Bio's application for delisting from Nasdaq First North Growth Market ("First North"). The...
► Artikel lesen
04.03.Diagonal Bio AB: Diagonal Bio has received conditional approval for listing on NGM Nordic SME117Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") has received conditional approval for listing on NGM Nordic SME ("NGM"). The first day of trading is planned for 19 March 2025. This means that...
► Artikel lesen
03.03.DIAGONAL BIO AB: Diagonal Bio applies for change of marketplace to NGM Nordic SME1
19.02.Diagonal Bio AB's announces last day of trading in BTU and first day of trading in warrants of series TO 22
18.02.Diagonal Bio AB resolves on a directed issue of units to all external underwriters4
12.02.DIAGONAL BIO AB: Diagonal Bio's CEO Karin Wehlin increases ownership1
07.02.Diagonal Bio AB: Diagonal Bio AB's rights issue of units oversubscribed270The subscription period in Diagonal Bio AB's ("Diagonal Bio" or the "Company") rights issue of units of initially approximately SEK 6.0 million ended on 6 February 2025 (the "Rights Issue"). The Rights...
► Artikel lesen
05.02.DIAGONAL BIO AB: Stall Goop conducts pilot test of LAMPlify®1
29.01.Diagonal Bio AB: Diagonal Bio announces positive pilot test results and secures order from StallZet72Diagonal Bio AB (publ) ("Diagonal Bio" or the "Company") announces an order valued at approximately SEK 150,000 from Daniel Redén, a renowned horse trainer at StallZet. The order comes as a result of...
► Artikel lesen
23.01.The subscription period of Diagonal Bio AB's rights issue of units commences today1
22.01.Diagonal Bio AB: Diagonal Bio AB publishes investment memorandum prior to upcoming rights issue of units155The subscription period of Diagonal Bio AB's ("Diagonal Bio" or the "Company") rights issue of units, which was resolved on 23 December 2024 by the Board of Directors together with the resolution on...
► Artikel lesen
17.01.DIAGONAL BIO AB: Nomination Committee change in Diagonal Bio (publ.)2
17.01.Bulletin from the Extraordinary General Meeting of Diagonal Bio AB on 17 January 20252
Seite:  Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1